Related Experiment Video
Updated: May 15, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Dietary inflammatory potential and its impact on gut microbiota in patients with mild cognitive impairment
Jinxiu Liu1, Yuping Zhang1, Xiaoqi Wu2
1The School of Nursing, Fujian Medical University, Fuzhou, China. qzliy2006@fjmu.edu.cn.
Abstract:
Diet can regulate systemic inflammation and the composition of the gut microbiota, which may play a significant role in the development of cognitive impairment. This study aims to explore the impact of inflammatory diets on gut microbes in patients with mild cognitive impairment (MCI) and to investigate the relationship between these microbes and cognitive function. Dietary inflammatory properties and gut microorganisms were analyzed using the energy-adjusted dietary inflammatory index (E-DII) and 16S rRNA in MCI patients. No significant differences in the diversity of the gut microbiota were observed among different E-DII groups. In the anti-inflammatory diet group, the gut microbiomes exhibited higher abundances of Christensenella and Oribacterium, while Streptococcus, Ruthenibacterium, Enterobacter, and Conservatibacter were significantly more prevalent in the pro-inflammatory diet group (P < 0.05). Specific oral and gut genera were found to be associated with MoCA, AVLT-LR, and STT-A scores (P < 0.05). A higher dietary inflammatory index was linked to lower overall cognitive function, as well as deficits in language, attention, and executive function. Additionally, specific gut microbial compositions were associated with cognitive performance.
Insights
A pro-inflammatory diet alters gut microbes in mild cognitive impairment (MCI) patients, impacting cognitive function. Specific gut bacteria linked to diet may influence brain health.
Area of Science:
- Microbiology
- Neuroscience
- Nutrition Science
Background:
- Diet significantly influences systemic inflammation and gut microbiota composition.
- Gut dysbiosis and inflammation are implicated in the development of cognitive impairment.
- Understanding the diet-microbiota-cognition axis is crucial for managing mild cognitive impairment (MCI).
Purpose of the Study:
- To investigate the impact of dietary inflammation on gut microbiota in MCI patients.
- To explore the relationship between specific gut microbes and cognitive function in MCI.
- To assess the association between dietary inflammatory index and cognitive performance.
Main Methods:
- Utilized the energy-adjusted dietary inflammatory index (E-DII) to quantify dietary inflammation.
- Analyzed gut microbial composition using 16S rRNA gene sequencing in MCI patients.
- Correlated microbial abundances and diversity with cognitive test scores (MoCA, AVLT-LR, STT-A).
Main Results:
- No significant differences in gut microbial diversity were found across E-DII groups.
- Anti-inflammatory diets were associated with higher abundances of *Christensenella* and *Oribacterium*.
- Pro-inflammatory diets correlated with increased prevalence of *Streptococcus*, *Ruthenibacterium*, *Enterobacter*, and *Conservatibacter*.
- Specific oral and gut microbial genera were significantly associated with cognitive scores.
- Higher E-DII scores were linked to poorer overall cognitive function, including deficits in language, attention, and executive function.
Conclusions:
- Dietary patterns, particularly inflammatory diets, are associated with distinct gut microbial profiles in MCI patients.
- Specific gut microbial compositions are linked to cognitive performance in individuals with MCI.
- Targeting gut microbiota through dietary interventions may offer a novel strategy for managing cognitive decline.
More Related Videos
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
What is Monogastric Digestion?